Invesco’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.16M | Buy |
264,854
+5,474
| +2% | +$49.6K | ﹤0.01% | 2509 |
|
|
2025
Q4 | $1.74M | Buy |
259,380
+29,704
| +13% | +$224K | ﹤0.01% | 2660 |
|
|
2025
Q3 | $1.99M | Sell |
229,676
-66,800
| -23% | -$520K | ﹤0.01% | 2613 |
|
|
2025
Q2 | $1.87M | Buy |
296,476
+12,354
| +4% | +$81.8K | ﹤0.01% | 2594 |
|
|
2025
Q1 | $1.82M | Buy |
284,122
+129,697
| +84% | +$1.07M | ﹤0.01% | 2572 |
|
|
2024
Q4 | $1.24M | Sell |
154,425
-750,742
| -83% | -$7.24M | ﹤0.01% | 2826 |
|
|
2024
Q3 | $11.4M | Buy |
905,167
+750,198
| +484% | +$9.69M | ﹤0.01% | 1765 |
|
|
2024
Q2 | $1.96M | Buy |
154,969
+4,279
| +3% | +$43K | ﹤0.01% | 2583 |
|
|
2024
Q1 | $720K | Buy |
150,690
+117,838
| +359% | +$547K | ﹤0.01% | 3160 |
|
|
2023
Q4 | $158K | Sell |
32,852
-1,817
| -5% | -$11.1K | ﹤0.01% | 3609 |
|
|
2023
Q3 | $251K | Sell |
34,669
-873
| -2% | -$6.98K | ﹤0.01% | 3517 |
|
|
2023
Q2 | $264K | Sell |
35,542
-81,028
| -70% | -$637K | ﹤0.01% | 3537 |
|
|
2023
Q1 | $808K | Buy |
116,570
+40,122
| +52% | +$369K | ﹤0.01% | 3003 |
|
|
2022
Q4 | $786K | Sell |
76,448
-41,688
| -35% | -$736K | ﹤0.01% | 3041 |
|
|
2022
Q3 | $2.15M | Buy |
118,136
+4,037
| +4% | +$175K | ﹤0.01% | 2611 |
|
|
2022
Q2 | $5.87M | Sell |
114,099
-7,586
| -6% | -$393K | ﹤0.01% | 2200 |
|
|
2022
Q1 | $8.96M | Sell |
121,685
-54,772
| -31% | -$4.88M | ﹤0.01% | 2023 |
|
|
2021
Q4 | $25.2M | Buy |
176,457
+115,761
| +191% | +$19.9M | 0.01% | 1402 |
|
|
2021
Q3 | $12.6M | Buy |
60,696
+10,034
| +20% | +$2.21M | ﹤0.01% | 1866 |
|
|
2021
Q2 | $10.8M | Sell |
50,662
-66,869
| -57% | -$12.3M | ﹤0.01% | 2011 |
|
|
2021
Q1 | $21.3M | Sell |
117,531
-22,897
| -16% | -$4.56M | 0.01% | 1493 |
|
|
2020
Q4 | $15.7M | Sell |
140,428
-29,709
| -17% | -$3.16M | ﹤0.01% | 1560 |
|
|
2020
Q3 | $18.4M | Sell |
170,137
-228,990
| -57% | -$27.9M | 0.01% | 1342 |
|
|
2020
Q2 | $33.3M | Sell |
399,127
-123,498
| -24% | -$4.72M | 0.01% | 1077 |
|
|
2020
Q1 | $7.1M | Buy |
+522,625
| New | +$4.42M | ﹤0.01% | 1695 |
|
|
2018
Q1 | – | Sell |
-11,063
| Closed | -$274K | – | 3753 |
|
|
2017
Q4 | $274K | Buy |
11,063
+96
| +0.9% | +$2.34K | ﹤0.01% | 3469 |
|
|
2017
Q3 | $250K | Buy |
10,967
+612
| +6% | +$13.7K | ﹤0.01% | 3500 |
|
|
2017
Q2 | $238K | Sell |
10,355
-707
| -6% | -$13.9K | ﹤0.01% | 3548 |
|
|
2017
Q1 | $283K | Buy |
11,062
+8,557
| +342% | +$235K | ﹤0.01% | 3524 |
|
|
2016
Q4 | $63K | Sell |
2,505
-306,711
| -99% | -$8.95M | ﹤0.01% | 3639 |
|
|
2016
Q3 | $12.9M | Sell |
309,216
-86,015
| -22% | -$11.1M | ﹤0.01% | 1351 |
|
|
2016
Q2 | $57.5M | Sell |
395,231
-156,407
| -28% | -$17.9M | 0.02% | 693 |
|
|
2016
Q1 | $56.9M | Buy |
551,638
+144,464
| +35% | +$15.5M | 0.02% | 677 |
|
|
2015
Q4 | $68.3M | Buy |
407,174
+88,710
| +28% | +$13.7M | 0.03% | 648 |
|
|
2015
Q3 | $45M | Sell |
318,464
-129,623
| -29% | -$29.1M | 0.02% | 784 |
|
|
2015
Q2 | $99.8M | Buy |
448,087
+79,032
| +21% | +$13.9M | 0.04% | 511 |
|
|
2015
Q1 | $61M | Sell |
369,055
-101,263
| -22% | -$16.4M | 0.02% | 712 |
|
|
2014
Q4 | $55.8M | Buy |
470,318
+49,137
| +12% | +$5.14M | 0.02% | 742 |
|
|
2014
Q3 | $35.1M | Buy |
421,181
+67,588
| +19% | +$6.11M | 0.01% | 955 |
|
|
2014
Q2 | $32.7M | Buy |
353,593
+84,384
| +31% | +$7.42M | 0.01% | 1007 |
|
|
2014
Q1 | $24.4M | Sell |
269,209
-84,854
| -24% | -$9.48M | 0.01% | 1108 |
|
|
2013
Q4 | $36.3M | Buy |
+354,063
| New | +$25M | 0.01% | 952 |
|
|
2013
Q3 | – | Sell |
-2,335
| Closed | -$96K | – | 4331 |
|
|
2013
Q2 | $96K | Buy |
+2,335
| New | +$101K | ﹤0.01% | 3968 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Invesco's NVAX Position: Q1 2026 in Review
Invesco increased its Novavax (NVAX) stake by 2.1% in Q1 2026, buying an estimated $49.6K and bringing the position to 264,854 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2509.
Invesco first reported a position in NVAX in Q2 2013 and has held it in 43 quarters since. The position peaked at $99.8M in Q2 2015. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Invesco held 264,854 shares of Novavax worth $2.16M as of Q1 2026.
- Invesco bought 5,474 Novavax shares in Q1 2026, an estimated $49.6K.
- Novavax made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2509 holding.
- Invesco first reported a position in Novavax in Q2 2013 and has held it in 43 quarters since.
- Invesco's Novavax position peaked at $99.8M in Q2 2015.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.